Incyte
IRS: 943136539
INCY
Incyte focuses on the discovery and development of small-molecule drugs.
Founded
1991 (30 years)
CEO
Hervé Hoppenot
Investor Relations
•
SEC
Revenue
2 billion (2020)
Want to see more? Sign up!
